425 related articles for article (PubMed ID: 16880823)
1. MAPK signalling: ERK5 versus ERK1/2.
Nishimoto S; Nishida E
EMBO Rep; 2006 Aug; 7(8):782-6. PubMed ID: 16880823
[TBL] [Abstract][Full Text] [Related]
2. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Squires MS; Nixon PM; Cook SJ
Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
[TBL] [Abstract][Full Text] [Related]
3. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons.
Cavanaugh JE; Ham J; Hetman M; Poser S; Yan C; Xia Z
J Neurosci; 2001 Jan; 21(2):434-43. PubMed ID: 11160424
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription.
Honda T; Obara Y; Yamauchi A; Couvillon AD; Mason JJ; Ishii K; Nakahata N
PLoS One; 2015; 10(2):e0117914. PubMed ID: 25689862
[TBL] [Abstract][Full Text] [Related]
6. ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.
Gilley R; March HN; Cook SJ
Cell Signal; 2009 Jun; 21(6):969-77. PubMed ID: 19249353
[TBL] [Abstract][Full Text] [Related]
7. Retrograde neurotrophic signaling in rat retinal ganglion cells is transmitted via the ERK5 but not the ERK1/2 pathway.
van Oterendorp C; Sgouris S; Schallner N; Biermann J; Lagrèze WA
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):658-65. PubMed ID: 24398098
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor promotes glial cell-derived neurotrophic factor gene expression mediated by activation of ERK5 in rat C6 glioma cells.
Obara Y; Nemoto W; Kohno S; Murata T; Kaneda N; Nakahata N
Cell Signal; 2011 Apr; 23(4):666-72. PubMed ID: 21130871
[TBL] [Abstract][Full Text] [Related]
9. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
10. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
11. ERK5: structure, regulation and function.
Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
[TBL] [Abstract][Full Text] [Related]
12. Alternative ERK5 regulation by phosphorylation during the cell cycle.
Iñesta-Vaquera FA; Campbell DG; Tournier C; Gómez N; Lizcano JM; Cuenda A
Cell Signal; 2010 Dec; 22(12):1829-37. PubMed ID: 20667468
[TBL] [Abstract][Full Text] [Related]
13. DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5.
Arkell RS; Dickinson RJ; Squires M; Hayat S; Keyse SM; Cook SJ
Cell Signal; 2008 May; 20(5):836-43. PubMed ID: 18280112
[TBL] [Abstract][Full Text] [Related]
14. The ERK5 and ERK1/2 signaling pathways play opposing regulatory roles during chondrogenesis of adult human bone marrow-derived multipotent progenitor cells.
Bobick BE; Matsche AI; Chen FH; Tuan RS
J Cell Physiol; 2010 Jul; 224(1):178-86. PubMed ID: 20232315
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response.
Hii CS; Anson DS; Costabile M; Mukaro V; Dunning K; Ferrante A
J Biol Chem; 2004 Nov; 279(48):49825-34. PubMed ID: 15381709
[TBL] [Abstract][Full Text] [Related]
16. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
17. ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells.
Obara Y; Nagasawa R; Nemoto W; Pellegrino MJ; Takahashi M; Habecker BA; Stork PJS; Ichiyanagi O; Ito H; Tomita Y; Ishii K; Nakahata N
Cell Signal; 2016 Mar; 28(3):177-189. PubMed ID: 26739108
[TBL] [Abstract][Full Text] [Related]
18. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
Raviv Z; Kalie E; Seger R
J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
[TBL] [Abstract][Full Text] [Related]
19. The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.
Wang X; Pesakhov S; Harrison JS; Kafka M; Danilenko M; Studzinski GP
Exp Cell Res; 2015 Jan; 330(1):199-211. PubMed ID: 25447310
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
